{
    "success": true,
    "data": {
        "id": 2051405,
        "msgid": "doctor-stresses-safety-when-choosing-collagen-stimulators-1792727616",
        "date": "2026-10-23 10:16:00",
        "title": "Doctor stresses safety when choosing collagen stimulators",
        "author": "",
        "source": "ANTARA_ID",
        "tags": "",
        "topic": "Business",
        "summary": "A dermatologist has urged consumers to prioritise safety, product quality and clinical evidence when selecting collagen-stimulating treatments. The comments come as Swedish biotech company Nordberg Medical launches its poly-L-lactic acid (PLLA) injectable product Julaine of Sweden in Indonesia in 2026.",
        "content": "<p>Jakarta (ANTARA) \u2014 The decline in collagen production with age has\ndriven the development of various skin-care approaches, including the\nuse of collagen stimulators.<\/p>\n<p>However, choosing a treatment method requires consideration of\nsafety, product quality and the clinical evidence supporting its\nuse.<\/p>\n<p>\u201cWhen choosing a collagen stimulator, safety is the top priority.\nPersonally, I always pay attention to a product\u2019s certifications,\u201d said\ndermatologist, venereologist and aesthetic medicine specialist Dr Deasy\nLius, Sp.DVE, in a statement on Friday.<\/p>\n<p>One approach in aesthetic medicine is the use of biostimulatory\nsubstances designed to encourage collagen formation. The treatment aims\nto improve skin quality gradually, although results may vary from person\nto person depending on skin condition and the body\u2019s response.<\/p>\n<p>As biomaterial technology develops, a range of biostimulator products\nwith different characteristics and mechanisms of action are being\ndeveloped. Evaluation should cover clinical evidence, expected benefits,\npotential side effects and the suitability of the product for the\npatient\u2019s condition.<\/p>\n<p>Against this backdrop, Swedish biotechnology company Nordberg Medical\nlaunched Julaine of Sweden in Indonesia in 2026. The poly-L-lactic acid\n(PLLA)-based injectable product is designed to stimulate collagen\nformation.<\/p>\n<p>\u201cJulaine has a strong safety profile, and I greatly appreciate\nNordberg Medical\u2019s efforts to obtain EU MDR certification and pursue\napproval from the US FDA. This reflects its commitment to quality and\npatient safety,\u201d Dr Deasy said.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/doctor-stresses-safety-when-choosing-collagen-stimulators-1792727616",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}